Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Rasmus Blechingberg Friis"'
Autor:
Karoline Dreyer Kattenhøj, Christine Louise Møberg, Louise Mahncke Guldbrandt, Rasmus Blechingberg Friis, Christophe Kamungu Mapendano, Søren Kjær Petersen, Christina Halgaard Bruvik Ruhlmann, Inge Marie Svane, Marco Donia, Eva Ellebaek, Henrik Schmidt
Publikováno v:
Cancers, Vol 16, Iss 14, p 2559 (2024)
Combination immunotherapy using ipilimumab/nivolumab is the golden standard treatment for patients with melanoma and asymptomatic brain metastases (MBM). However, it remains uncertain if real-world patients have the same treatment effects compared to
Externí odkaz:
https://doaj.org/article/58cd47ee995b49b4b58f957862e66bb3
Autor:
Niels Henrik Hjollund, Rasmus Blechingberg Friis, Caroline Trillingsgaard Mejdahl, Helle Pappot, Halla Skuladottir
Publikováno v:
BMJ Open, Vol 10, Iss 6 (2020)
Objectives To design an electronic questionnaire for symptom monitoring and to evaluate the feasibility, usability and acceptability when applied to patients with metastatic lung cancer.Setting Single-centre feasibility study.Participants Patients wi
Externí odkaz:
https://doaj.org/article/8cce67a618db4b04897965517d533c3d
Autor:
Dag Rune Stormoen, Gry Assam Taarnhøj, Rasmus Blechingberg Friis, Christoffer Johansen, Helle Pappot
Publikováno v:
Stormoen, D R, Taarnhøj, G A, Friis, R B, Johansen, C & Pappot, H 2023, ' Association of patient-reported pain with survival in bladder cancer : a post-hoc analysis of the iBLAD trial ', Acta Oncologica . https://doi.org/10.1080/0284186X.2023.2199461
Association of patient-reported pain with survival in bladder cancer: a post-hoc analysis of the iBLAD trial
Autor:
Niels Henrik I. Hjollund, Louise Pape Larsen, Annette Ladefoged de Thurah, Birgith Engelst Grove, Halla Skuladottir, Hanne Linnet, Rasmus Blechingberg Friis, Søren Paaske Johnsen, Ole May, Annesofie Lunde Jensen, Troels Krarup Hansen, Gry Assam Taarnhøj, Lærke Kjær Tolstrup, Helle Pappot, Per Ivarsen, Liv Dørflinger, Anne Jessen, Nanna Toxvig Sørensen, Liv Marit Valen Schougaard, The AmbuFlex team
Publikováno v:
Hjollund, N H I, Larsen, L P, de Thurah, A L, Grove, B E, Skuladottir, H, Linnet, H, Friis, R B, Johnsen, S P, May, O, Jensen, A L, Hansen, T K, Taarnhøj, G A, Tolstrup, L K, Pappot, H, Ivarsen, P, Dørflinger, L, Jessen, A, Sørensen, N T, Schougaard, L M V & Team, T A 2023, ' Patient-reported outcome (PRO) measurements in chronic and malignant diseases : ten years' experience with PRO-algorithm-based patient-clinician interaction (telePRO) in AmbuFlex ', Quality of Life Research, vol. 32, no. 4, pp. 1053-1067 . https://doi.org/10.1007/s11136-022-03322-9
Background Patient-reported Outcome (PRO) measures may be used as the basis for out-patient follow-up instead of fixed appointments. The patients attend follow-up from home by filling in questionnaires developed for that specific aim and patient grou
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ebdefd927c6a5f34f6c5b56241225d79
https://vbn.aau.dk/da/publications/07951fa2-17fb-48b1-8f18-360420294c75
https://vbn.aau.dk/da/publications/07951fa2-17fb-48b1-8f18-360420294c75
Autor:
Jesper Medom Vestergaard, Gry Assam Taarnhøj, Helle Pappot, Halla Skuladottir, Niels Henrik Hjollund, Rasmus Blechingberg Friis
Publikováno v:
Friis, R B, Hjøllund, N H, Pappot, H, Taarnhøj, G A, Vestergaard, J M & Skuladottir, H 2021, ' Patient-Reported Outcome Measures Used in Routine Care Predict for Survival at Disease Progression in Patients With Advanced Lung Cancer ', Clinical Lung Cancer, vol. 22, no. 2, pp. e169-e179 . https://doi.org/10.1016/j.cllc.2020.09.014
Background: Patient-reported outcome (PRO) measures have been increasingly implemented in routine care to aid in clinical decision-making. However, the prognostic value of PRO measures as a tool for decision making is not easily interpreted by clinic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3dc323dd4774d3e6fb7117ce70be078f
https://pure.au.dk/portal/da/publications/patientreported-outcome-measures-used-in-routine-care-predict-for-survival-at-disease-progression-in-patients-with-advanced-lung-cancer(d191cd52-a6e3-4f1c-be89-6278b659751a).html
https://pure.au.dk/portal/da/publications/patientreported-outcome-measures-used-in-routine-care-predict-for-survival-at-disease-progression-in-patients-with-advanced-lung-cancer(d191cd52-a6e3-4f1c-be89-6278b659751a).html
Autor:
Halla Skuladottir, Helle Pappot, Rasmus Blechingberg Friis, Niels Henrik Hjollund, Caroline Trillingsgaard Mejdahl
Publikováno v:
BMJ Open
Friis, R B, Hjollund, N H, Mejdahl, C T, Pappot, H & Skuladottir, H 2020, ' Electronic symptom monitoring in patients with metastatic lung cancer : a feasibility study ', BMJ Open, vol. 10, no. 6, e035673 . https://doi.org/10.1136/bmjopen-2019-035673
BMJ Open, Vol 10, Iss 6 (2020)
Friis, R B, Hjollund, N H, Mejdahl, C T, Pappot, H & Skuladottir, H 2020, ' Electronic symptom monitoring in patients with metastatic lung cancer : A feasibility study ', BMJ Open, vol. 10, no. 6, e035673 . https://doi.org/10.1136/bmjopen-2019-035673
Friis, R B, Hjollund, N H, Mejdahl, C T, Pappot, H & Skuladottir, H 2020, ' Electronic symptom monitoring in patients with metastatic lung cancer : a feasibility study ', BMJ Open, vol. 10, no. 6, e035673 . https://doi.org/10.1136/bmjopen-2019-035673
BMJ Open, Vol 10, Iss 6 (2020)
Friis, R B, Hjollund, N H, Mejdahl, C T, Pappot, H & Skuladottir, H 2020, ' Electronic symptom monitoring in patients with metastatic lung cancer : A feasibility study ', BMJ Open, vol. 10, no. 6, e035673 . https://doi.org/10.1136/bmjopen-2019-035673
ObjectivesTo design an electronic questionnaire for symptom monitoring and to evaluate the feasibility, usability and acceptability when applied to patients with metastatic lung cancer.SettingSingle-centre feasibility study.ParticipantsPatients with
Autor:
Rasmus Blechingberg Friis, Niels Henrik Hjollund, Caroline Mejdahl, Helle Pappot, Halla Skuladottir
Publikováno v:
Friis, R B, Hjollund, N H, Mejdahl, C, Pappot, H & Skuladottir, H 2019, ' Development and feasibility of the use of electronic symptom self-reporting as a tool for intensified disease monitoring in lung cancer in Denmark ', Isoqol 2019, San Diego, United States, 20/10/2019 pp. S121-S121 .
Aarhus University
Aarhus University
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::998c47573dc7d4b8e0bef58b12af80b5
https://pure.au.dk/portal/da/publications/development-and-feasibility-of-the-use-of-electronic-symptom-selfreporting-as-a-tool-for-intensified-disease-monitoring-in-lung-cancer-in-denmark(db06605b-8b67-44ff-9e4e-1fc3c30af2ee).html
https://pure.au.dk/portal/da/publications/development-and-feasibility-of-the-use-of-electronic-symptom-selfreporting-as-a-tool-for-intensified-disease-monitoring-in-lung-cancer-in-denmark(db06605b-8b67-44ff-9e4e-1fc3c30af2ee).html
Publikováno v:
Nielsen, H M, Friis, R B, Linnet, S & Offersen, B V 2017, ' Loco-regional morbidity after breast conservation and axillary lymph node dissection for early breast cancer with or without regional nodes radiotherapy, perspectives in modern breast cancer treatment : the Skagen Trial 1 is active ', Acta Oncologica, vol. 56, no. 5, pp. 713-718 . https://doi.org/10.1080/0284186X.2016.1277261
Background: Axillary lymph node dissection (ALND) and adjuvant radiotherapy (RT) in early breast cancer are associated with a risk of morbidity, including lymphedema and impaired shoulder mobility. The aim of this study was to evaluate loco-regional
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e409b496706189e11d4606141a2e25ad
https://pure.au.dk/portal/da/publications/locoregional-morbidity-after-breast-conservation-and-axillary-lymph-node-dissection-for-early-breast-cancer-with-or-without-regional-nodes-radiotherapy-perspectives-in-modern-breast-cancer-treatment(c8f60a2f-0025-4baf-a250-614d88d140e3).html
https://pure.au.dk/portal/da/publications/locoregional-morbidity-after-breast-conservation-and-axillary-lymph-node-dissection-for-early-breast-cancer-with-or-without-regional-nodes-radiotherapy-perspectives-in-modern-breast-cancer-treatment(c8f60a2f-0025-4baf-a250-614d88d140e3).html